Skip to content

Clinical trials

Terminated Lymphoma, Mantle-Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Status: Terminated Country / region: South Korea Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20161
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IGM Biosciences, Inc.1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
Samsung Medical Center1
TG Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell5
Lymphoma, Follicular4
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Recurrence2
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.